chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I began feeling short of breath after doing minor tasks in my own (doing laundry, walking up steps, etc.)  during the  2nd week after my covid vaccination. On the morning of April 10th I awoke to feeling severely winded as if I had run 18 marathons just to walk up 3 steps or to walk across a room.  I was taken to the ER where they performed a catscan on me and could see that my lungs were ?full? of blood clots and I was experiencing a pulmonary embolism.  I do not smoke, take birth control pills, I do not drink.  There is no family history of clotting, nor did any traumatic incident happen within the last two weeks to cause this.
Extremely itchy blisters on bilateral hands, elbows and feet  consistent with a new diagnosis of dyshydrotic eczema
2-3 patients return to the office 7-10 days after administration of VARIVAX due to a local reaction. The doctor ended up diagnosing each of those patients with cellulitis / one patient had a reaction on the leg after the 2nd dose of VARIVAX; This spontaneous report was received from a registered nurse, referring to a child patient of unknown gender with approximately 5-years-old. Information regarding the patient's pertinent medical history, concomitant therapies, and previous drug reactions or allergies were unknown by the reporter.   On an unknown date in 2020 (reported as "over the past 6 months"), the patient was vaccinated with the second dose of  varicella virus vaccine live (oka/merck) (VARIVAX), administered subcutaneously (dose, vaccination scheme frequency, anatomical site of vaccination, lot number and expiration date were unknown by the reporter) as prevention of varicella.  On an unknown date in 2020 (reported as "within the past 6 months"), the reporter stated that the patient returned to the office 7 to 10 days after administration of varicella virus vaccine live (oka/merck) (VARIVAX) due to a local reaction. Subsequently, the doctor ended up diagnosing the patient with cellulitis and prescribed cephalexin (KEFLEX). Additionally, the registered nurse reported that the patient had this reaction on the leg. The patient did not have any disability or incapacity due to the events, no overdose occurred, no laboratory tests were performed neither were hospitalized.  At the time of reporting, it was reported that patient had recovered from cellulitis on an unknown date in 2020. The causal relationship between the above-mentioned event and the varicella virus vaccine live (oka/merck) (VARIVAX) was not reported.  Upon internal review, cellulitis was considered a medically significant event.  This was one of two reports received from the same reporter.  As of 06-AUG-2020, a telephone attempt trying to obtain additional information has been unsuccessful.; Sender's Comments:  US-009507513-2008USA001706:
This spontaneous case was reported by a consumer and describes the occurrence of DIARRHEA (severe diarrhea) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0165M20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included ATORVASTATIN, FERROUS SULFATE, LISINOPRIL, OXYBUTYNIN CHLORIDE, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and PANTOPRAZOLE for an unknown indication. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced DIARRHEA (severe diarrhea). At the time of the report, DIARRHEA (severe diarrhea) had resolved. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable. Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow up received and added second dose information, updated action taken(changed to not applicable) and event outcome (changed to resolved).
I basically - the symptoms are always present still but it can get worse and slightly better at times; they ebb and flow a little bit but have been constant since the time they first appeared 20 minutes after the vaccine.  Tightness around my left eye. With addition of feeling like something like something is in my left eye - like dirt or an eyelash or something. A constant earache. Left temple headache; Constant grip around my mouth around the left side of mouth - like something gripping me there. Tingly feeling all over the left side of my face.  Also, a little bit of pain - residual pain in my neck and my arm that was very present after I had the shot but now it kind of a minor residual thing that has never gone away. I have no outward appearance of it. Have been told that it's not Bells Palsy because of no motor signs that are visible otherwise it seems like it is Bells Palsy. Tried a Steroid treatment - Z Pack Prednisone: but the doctor never prescribed them right away - it was a month later or two months later afterwards. I have been on Valacyclovir  - 2  - 500 mg tablets daily and I am still on it. It's not having any affect after the two weeks I have been on it. I have taken anti-inflammatories- ibuprofen. I have taken 7.5 mg Meloxicam for a week to no affect. I have taken Nortriptyline - 10 mg  once before bedtime - and that didn't help. 300 mg of Gabapentin for a week and that didn't help at all. Have been Acetyl L Carnitine; Alpha lipoic acid; Ascorbic Acid capsules  1000 mg twice daily; Monolaurin - 600 mg twice daily - no affect yet. I am on Monolaurin and Ascorbic Acid with the Valacyclovir right now.
3 or 4 days after my first dose, I starting having random small stinging pustules on my chest and abdomen continuing 1 or 2 per day. This continued for many weeks so I waited 20 weeks for the frequency to lessen to about 1 per 4 days before having my second Shingrix dose on April 30, 2021.  After the second dose, the pustules seemed to increase in frequency again and now after 17 weeks they appear to be diminishing at this point to 1 per week.  Basically I viewed this as an inconvenience and no big deal so I never sought any medical attention, but wanted to report it in case others have the same issue.
On the first day I had a sore arm. Then 48 hrs after my vaccine I started having shortness of breath. I seen my doctor the same day on 01/4/2021. They did a covid test & a lung scan  & everything came out good.
AFTER RECEIVING VACCINE 27 YEAR OLD COMPLAINED OF BEING ANXIOUS. ON SITE EMS RESPONDED, VITALS ARE BELOW. SHE WAS MONITORED AND RECOVERED AND RELEASED FROM TO HOME
Dementia; missed her second dose; A spontaneous report was received from a consumer concerning a 99 years old, male patient who developed Dementia.  The patient's medical history includes Dementia from 07-MAR-2021  Concomitant product use was not provided/unknown by the reporter.   The first of two planned doses of mRNA-1273 (Batch number:03920K20A on 05-FEB-2021) intramuscularly for prophylaxis of COVID-19 infection  After 1 st dose patient was admitted to the hospitaland was having dementia.   The second dose of mRNA-1273 was discontinued in response to dementia. The patient missed her second dose.  Treatment information was not provided.   Action taken with mRNA-1273 in response to the event was not provided/unknown.  The outcome of missed dose was resolved and for dementia was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Severe arm pain, pain level 6, otc pain meds taken (muscle relaxer, Vicodin, Tylenol, ibuprofen all tried) Going on 2 weeks  Pain spans from bicep, up to base of skull, down left side of mid back
Deep Vein Thrombosis, pulmonary embolism blood thinners  no final outcome as I am still in treatment
pt exp severe, serious & personal injuries & complications, severe shock to nervous system & numerous internal injuries p/vax w/rubella in JUL 1989;
Adverse event: Nursing & rehab facility incorrectly filled out consent form, patient was unable to confirm or deny medical information. Information found after vaccination given. Pfizer given to a patient who already received two doses of Moderna. Treatment: None needed  Adverse event: None immediately noted
maculopapular rash beginning approx 24hr p/vax;rash on head, trunk, upper legs;
Friday (11/9) 0.5 ml PNEUMOVAX IM (L) deltoid Sat (11/10) patient noticed tenderness at inj site. She reported that it wasn't excessive nor severe Sun (11/11) pt calls to report "red blotch" forming below inj site & becoming "very" tender - We referred her to ER where she was treated for cellulitis. ER dr ordered KEFLEX 500 QID x 10d.
Havrix adult dose administered to a child instead of Vaqta; Havrix adult dose administered to a child instead of Vaqta; This non-serious case was reported by a nurse via call center representative and described the occurrence of overdose in a 2-year-old male patient who received HAV (Havrix adult) (batch number 3J9J4, expiry date 30-AUG-2025) for prophylaxis.   On 15-JUN-2023, the patient received Havrix adult. On 15-JUN-2023, an unknown time after receiving Havrix adult, the patient experienced overdose (Verbatim: Havrix adult dose administered to a child instead of Vaqta) and adult product administered to child (Verbatim: Havrix adult dose administered to a child instead of Vaqta). The outcome of the overdose and adult product administered to child were unknown.   Additional Information: GSK Receipt Date: 15-JUN-2023 The reporter consented to follow up. The reporter reported that a 2 year old was administered an adult dose of Havrix instead of Vaqta, which led to overdose and adult product administered to child.
A nurse reported that a 20 month old male received his 2nd dose of Prevnar along with DTP and Poliomyelitis inactivated in December 2001. In April, 2001, he developed a fever and was taken to his pediatrician. Blood cultures were drawn and were positive for S. Pneumonia. Serotypes were not available on the date the report was submitted. Septicemia streptococcal was considered to be medically important. Follow up information received from vaccine provider on 05/15/01 provided the diagnosis of strep pneumococcal pneumoniae; the date of adverse event onset, as well as, the complete dates and lot numbers for each of the two Prevnar administrations. the reporter indicated that the patient recovered. Additional info from the reporter on 05/29/2001 provided the pt's name and date when the pt was hospitalized.  The hospital laboratory could not provide a serotype. The pt remained recovered.
chills; headache; fever went up to 100.6F; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), HEADACHE (headache) and PYREXIA (fever went up to 100.6F) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 15-Feb-2021, the patient experienced CHILLS (chills), HEADACHE (headache) and PYREXIA (fever went up to 100.6F). At the time of the report, CHILLS (chills), HEADACHE (headache) and PYREXIA (fever went up to 100.6F) had not resolved.            No treatment or concomitant medications were reported.
3 days after vaccine administered-fever to 102 degrees.  2 small pox noted in diaper area.  No treatment required except Tylenol/Motrin.
high temp 104 x 2 1/2 days-severe red rash on 3rd day;covering entire body;
Patient came in and wanted the Prevnar-13 because her doctor wanted it done as soon as possible. We explained that there was a new Prevnar-20 that was to be released but we did not have it yet. She was told that she would need a Pneumovax-23 in 1 year and she was fine with that.
No adverse symptoms reported; the patient was administered a dose of MMR II via the intramuscular route rather than the recommended subcutaneous route; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history, drug reactions or allergies and concomitant medications was provided.  On 02-JUL-2020, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA (recombinant human albumin)) (M-M-R II) lot # S015093, expiration date 15-MAY-2021 (strength, dose and frequency were not reported) for prophylaxis. The vaccine was reconstituted with sterile diluent lot # S038697, expiration date 10-AUG-2022 (reported as 10-MAY-2022) and administrated via the intramuscular route rather than the recommended subcutaneous route.  No adverse symptoms were reported. The outcome of the events was unknown.
Pt had redness on left thigh at injection site. No complaints of pain, fever, difficulty with breathing or problem walking.
sore muscles and joints swollen hand and wrist.; his hand and wrist on both arms hurt; sore muscles and joints swollen hand and wrist.; his hand and wrist on both arms hurt; sore muscles and joints swollen hand and wrist.; he was down all day; This is a spontaneous report from a contactable consumer (patient) via Pfizer sponsored program. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number was not reported), via an unspecified route of administration on 04Feb2021 as dose 2, single for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number was not reported), via an unspecified route of administration on unspecified date as dose 1, single for covid-19 immunisation. The patient experienced sore muscles and joints, swollen hand and wrist. He said he was down all day from the vaccine on 04Feb2021. On 05Feb2021 felt better but then a few days later his hand and wrist on both arms hurt and are very swollen, more on arm where vaccine taken. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Breakthrough case admission after 4 vaccines Pfizer 2/15/21 Lot# El9267  Pfizer 3/8/21 Lot#EN6199;  Pfizer 10/4/21 Lot# FE2590;  Pfizer 7/14/22 Lot# FJM991
Pt reported shellfish allergy on form. Got moderna vaccine and was asked to wait 30 minutes. After waiting period she checked back at counter and said she felt like she has a slight eyelid swelling but it went down and she felt fine and left. She wasn't given any medication. She called next day 6/25 to cancel second dose and reported couple hours later after she went home, she had some throat swelling similar to a shellfish allergy but didn't take anything for it and didn't call doctor, and that also went away a few hours later and completing upon waking up next day.
sinus infection; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (sinus infection) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SINUSITIS (sinus infection). At the time of the report, SINUSITIS (sinus infection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient mentioned having a sinus infection and his HCP putting him on an antibiotic, caller wanted to know if the antibiotic would interfere with his covid vaccine? He is inbetween doses. When I attempted to gather more information from the caller, he insisted that his sinus infection was not from the vaccine and was not able to discuss further.
1520 Syncope, Pale, Cool, Moist 1521 Seizure 45 Seconds, 911 Called 1522 Patient awoke, Post Ictal 30 seconds 1523 BP: 134/70, HR: 58, RR: 16, SpO2: 94 1525 BP: 120/80 HR: 64, RR: 16, SpO2: 96 15:28 Fire and EMS Arrived and assumed patient care 1532 Patient signed EMS AMA 1550 Patient released after prolonged observation.
She got her vaccine, her arm got just a tiny bit sore before she went to bed.  Then on Sunday her arm was a little sore and she was tired and lethargic.  She did not feel good, was exhausted.  When she went to go to bed her stomach started feeling queasy and she felt like she was coming down with the flu.  Then on Monday when she got up she didn't feel good at all, and her ice pack leaked and there was water everywhere.  She leaned over to get a towel, felt dizzy and fell on the floor.  She laid on the floor for 5-10 minutes, had her husband come in and help her up.  She had injection site pain and tenderness, tiredness, headache and chills.  Her temp was 97.4, she only took it once.  She also had diarrhea, she had dry heaves, and then had vomiting, as well as nausea.  She did not eat anything, continued with the nausea and vomiting, as well as dizziness.  She did not black out at any point.   She laid in bed all day yesterday, did not eat or drink anything until 8-9:00 PM last night.  She did not call her doctor as she felt it was due to the vaccine, and if she did not feel good today she would have called the doctor and gone in.  Today, she is feeling better, and close to being 100% back to normal.  Knows that she needs to eat something, has a headache, and needs to take her medicine and take some water.
This case was reported by a pharmacist and described the occurrence of swelling injection site in an adult subject of unspecified gender who was vaccinated with FLUARIX, (GlaxoSmithKline). On an unspecified date, the subject received unspecified dose of FLUARIX (unknown route and injection site). On an unspecified date, 2 days after vaccination with FLUARIX, the subject experienced swelling injection site, injection site warmth and injection site hives. At the time of reporting, the events were improved. The pharmacist considered the events were probably related to vaccination with FLUARIX. This case is one of the 5 cases reported by the same reporter for the same vaccine.
9/24/21 12:00pm dull head ache, numb tingling feeling on the right side of scalp. 9/25/21  woke up around 8am with binocular double vision, continues through 9/27.  9/27/21 sought care at Clinic.  Saw NP who referred the client to the emergency room.  There the client reports he had an MRI and blood work.  No abnormalities were found.  He was scheduled for a neurologist appointment next week.
This spontaneous report was received from a medical assistant via a company representative referring to herself, a 58 year old female patient. The patient's medical history and concurrent condition were not provided. In approximately November 2015 (reported as more than a month ago), the patient was vaccinated with a dose of ZOSTAVAX (Lot #, route, dose, concentration and anatomical location were not provided). Concomitant medications were not reported. In approximately November 2015  (reported as 24 to 48 hours after receiving the vaccine), the patient experienced vaccination site induration in an unspecified location in an unspecified arm in which the ZOSTAVAX was received. On an unspecified date in 2015, the patient sought medical attention by seeing the physician. The outcome of vaccination site induration was unknown. The primary reporter did not provide the causality between ZOSTAVAX and vaccination site induration. Additional information has been requested.
1-2 weeks after vaccine, red, indurated but non-tender area at site of injection. Resolved after 1 month.
I already have Thrombocytopenia, but platelets (which were averaging 90,000-95,000) dropped to 59,000
itch/itching after receiving the vaccine; This is a spontaneous report from a contactable consumer or other non-healthcare professional (Patient).  A female patient of age 63 (units unknown) received bnt162b2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection; Batch/Lot number was not reported) via an unspecified route of administration on 20Mar2021 12:00 as dose 1, single for covid-19 immunization. Medical history and concomitant medications were not reported. Patient known allergies included as included penicillin allergy from an unknown date and unknown if ongoing. It is reported that, patient got Pfizer's covid vaccine on 20Mar2021 at noon and sat for the half hour to be monitored after the vaccine. On the same date 20Mar2021 at 5 pm, about 5 hours later, she had a slight itch and it was very mild. Outside of the itch, she has had no other symptoms and also stated it was now 48 hours after her first vaccination and the itching was very mild but she still has it. She does not know if the itch was related to the vaccine, it was not a side effect from what she understands. She did not have itching before the vaccine but has it after. Patient was asking that if she get the second one, as she heard the side effects could be worse with the second shot. She was not seeking medical advise but wanted to know if itching was a side effect of the vaccine. No Investigation Assessment was provided. The outcome of the event was not recovered.   No follow up attempts are possible. Information about Lot/batch number cannot be obtained. No further information is expected.
No adverse event; A pediatrician reports that they inadvertently administered the bivalent dose instead of the monovalent dose for the primary series (2 as 2nd doses and 1 as 1st dose); This spontaneous case was reported by a physician and describes the occurrence of WRONG PRODUCT ADMINISTERED (A pediatrician reports that they inadvertently administered the bivalent dose instead of the monovalent dose for the primary series (2 as 2nd doses and 1 as 1st dose)) and NO ADVERSE EVENT (No adverse event) in a 2-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch nos. 216K22A and 216K22A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 15-Feb-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 15-Mar-2023, received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. On 15-Mar-2023, the patient experienced WRONG PRODUCT ADMINISTERED (A pediatrician reports that they inadvertently administered the bivalent dose instead of the monovalent dose for the primary series (2 as 2nd doses and 1 as 1st dose)). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (A pediatrician reports that they inadvertently administered the bivalent dose instead of the monovalent dose for the primary series (2 as 2nd doses and 1 as 1st dose)) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (A pediatrician reports that they inadvertently administered the bivalent dose instead of the monovalent dose for the primary series (2 as 2nd doses and 1 as 1st dose)).    Concomitant medication not reported. Treatment medication not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-716005 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 15-Mar-2023: Significant Live follow up appended : Patient and Dosage information Updated; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-716005:1st infant patient
I was having advanced edema in my legs and went to the ER clinic in my neighborhood when it was determined my hemaglobin was 4.2 and I was taken to the ER where after 5 days was diagnosed with hemolytic anemia brought on by a foreign virus in my blood.